People: Procter & Gamble Co (PG.N)
14 Jul 2020
Mr. Thomas M. Finn is President - Personal Health Care of the Company. Mr. Tom Finn leads P&G’s multi-billion-dollar over-the-counter Personal Health Care business, including brands such as Metamucil, Pepto-Bismol, Prilosec OTC, and Vicks—currently the number one retail over-the-counter brand in the world. Tom’s career spans more than three decades and reflects vast experience and deep knowledge in the health care field. He joined P&G in 1984 as a brand assistant on the Entex brand and went on to serve in a wide range of marketing and general management assignments with responsibilities that include managing P&G’s divested Rx business, upstream technology development, various customer-facing positions, and strategic partnerships—including a previous joint venture with Teva Pharmaceuticals, a global partnership with Alere/Abbott in consumer diagnostics—and the recently- announced acquisition of the Merck KGaA consumer health care business. In addition to his current responsibilities at P&G, Tom is very active in the broader health care delivery and transformation landscape in Ohio. He currently serves on Cincinnati Children’s Medical Center Board of Trustees. In addition, he also serves on the committee working to bring a National Cancer Institute Center to Cincinnati. He was a long-standing member of the Board of Directors of TriHealth, Inc., and in 2012, was appointed by former Ohio Governor, John Kasich to serve on his Health Care Payment Innovation Advisory Council.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|